{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:20:12Z","timestamp":1790036412755,"version":"4.0.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T00:00:00Z","timestamp":1440547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s11882-015-0562-9","type":"journal-article","created":{"date-parts":[[2015,8,25]],"date-time":"2015-08-25T07:44:13Z","timestamp":1440488653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases"],"prefix":"10.1007","volume":"15","author":[{"given":"Jonathan J.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,26]]},"reference":[{"key":"562_CR1","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1053\/j.gastro.2008.09.012","volume":"135","author":"MD Kappelman","year":"2008","unstructured":"Kappelman MD et al. Direct health care costs of Crohn\u2019s disease and ulcerative colitis in US children and adults. Gastroenterology. 2008;135:1907\u201313.","journal-title":"Gastroenterology"},{"key":"562_CR2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/JOM.0b013e318181b8ca","volume":"50","author":"TB Gibson","year":"2008","unstructured":"Gibson TB et al. The direct and indirect cost burden of Crohn\u2019s disease and ulcerative colitis. J Occup Environ Med. 2008;50:1261\u201372.","journal-title":"J Occup Environ Med"},{"issue":"3","key":"562_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/gut.42.3.387","volume":"42","author":"TR Orchard","year":"1998","unstructured":"Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut. 1998;42(3):387\u201391.","journal-title":"Gut"},{"key":"562_CR4","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/MOG.0b013e32833f1195","volume":"26","author":"J Hansen","year":"2010","unstructured":"Hansen J, Gulati A, Sartor RB. The role of mucosal immunity and host genetics in defining intestinal commensal bacteria. Curr Opin Gastroenterol. 2010;26:564\u201371.","journal-title":"Curr Opin Gastroenterol"},{"key":"562_CR5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers D et al. The treatment-naive microbiome in new-onset Crohn\u2019s disease. Cell Host Microbe. 2014;15:382\u201392.","journal-title":"Cell Host Microbe"},{"key":"562_CR6","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1172\/JCI75436","volume":"124","author":"Y Haberman","year":"2014","unstructured":"Haberman Y et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest. 2014;124:3617\u201333. Largest microbiome study in human IBD patients published to date.","journal-title":"J Clin Invest"},{"key":"562_CR7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","volume":"160","author":"JM Norman","year":"2015","unstructured":"Norman JM et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;160:447\u201360. First large-scale virome study in human IBD patients.","journal-title":"Cell"},{"key":"562_CR8","doi-asserted-by":"crossref","unstructured":"Chehoud C et al. Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015.","DOI":"10.1097\/MIB.0000000000000454"},{"key":"562_CR9","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1221789","volume":"336","author":"ID Iliev","year":"2012","unstructured":"Iliev ID et al. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science. 2012;336:1314\u20137. Demonstrates that fungal elements play a role in the pathogenesis of experimental IBDs.","journal-title":"Science"},{"key":"562_CR10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0140-6736(91)90663-A","volume":"338","author":"P Rutgeerts","year":"1991","unstructured":"Rutgeerts P et al. Effect of faecal stream diversion on recurrence of Crohn\u2019s disease in the neoterminal ileum. Lancet. 1991;338:771\u20134.","journal-title":"Lancet"},{"key":"562_CR11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","volume":"114","author":"GR D\u2019Haens","year":"1998","unstructured":"D\u2019Haens GR et al. Early lesions of recurrent Crohn\u2019s disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology. 1998;114:262\u20137.","journal-title":"Gastroenterology"},{"key":"562_CR12","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/ajg.2010.84","volume":"105","author":"T Ohkusa","year":"2010","unstructured":"Ohkusa T et al. Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial. Am J Gastroenterol. 2010;105:1820\u20139.","journal-title":"Am J Gastroenterol"},{"key":"562_CR13","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.crohns.2014.05.010","volume":"8","author":"D Turner","year":"2014","unstructured":"Turner D, Levine A, Kolho KL, Shaoul R, Ledder O. Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report. J Crohns Colitis. 2014;8:1464\u201370.","journal-title":"J Crohns Colitis"},{"key":"562_CR14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1053\/j.gastro.2008.07.010","volume":"135","author":"GR D\u2019Haens","year":"2008","unstructured":"D\u2019Haens GR et al. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn\u2019s disease: a controlled randomized trial. Gastroenterology. 2008;135:1123\u20139.","journal-title":"Gastroenterology"},{"key":"562_CR15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5085(82)80332-6","volume":"83","author":"LJ Brandt","year":"1982","unstructured":"Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn\u2019s disease: a follow-up study. Gastroenterology. 1982;83:383\u20137.","journal-title":"Gastroenterology"},{"key":"562_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ibd.20608","volume":"15","author":"KT Thia","year":"2009","unstructured":"Thia KT et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn\u2019s disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2009;15:17\u201324.","journal-title":"Inflamm Bowel Dis"},{"key":"562_CR17","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/0016-5085(95)90121-3","volume":"108","author":"P Rutgeerts","year":"1995","unstructured":"Rutgeerts P et al. Controlled trial of metronidazole treatment for prevention of Crohn\u2019s recurrence after ileal resection. Gastroenterology. 1995;108:1617\u201321.","journal-title":"Gastroenterology"},{"key":"562_CR18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2005.01.010","volume":"128","author":"P Rutgeerts","year":"2005","unstructured":"Rutgeerts P et al. Ornidazole for prophylaxis of postoperative Crohn\u2019s disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2005;128:856\u201361.","journal-title":"Gastroenterology"},{"key":"562_CR19","doi-asserted-by":"crossref","unstructured":"Prantera C et al. Rifaximin-extended intestinal release induces remission in patients with moderately active Crohn\u2019s disease. Gastroenterology. 2012;142:473\u2013481 e4. Large, randomized, controlled trial that demonstrates a clinical benefit of a non-absorbed antibiotic in Crohn\u2019s disease.","DOI":"10.1053\/j.gastro.2011.11.032"},{"key":"562_CR20","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ajg.2010.218","volume":"105","author":"A Tursi","year":"2010","unstructured":"Tursi A et al. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2010;105:2218\u201327.","journal-title":"Am J Gastroenterol"},{"key":"562_CR21","unstructured":"Sood A et al. The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis. Clin Gastroenterol Hepatol. 2009;7:1202\u20139, 1209 e1."},{"key":"562_CR22","unstructured":"Fedorak RN et al. The probiotic VSL#3 has anti-inflammatory effects and could reduce endoscopic recurrence after surgery for Crohn\u2019s disease. Clin Gastroenterol Hepatol. 2015;13:928\u201335 e2. First randomized, controlled trial of probiotics to prevent post-operative Crohn\u2019s disease recurrence. There was no significant difference in the primary endpoint between treatment and control groups."},{"key":"562_CR23","doi-asserted-by":"crossref","unstructured":"Moayyedi P et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology. 2015;149:102\u2013109 e6. Randomized controlled trial demonstrating effectiveness of fecal microbial transplant in inducing remission in ulcerative colitis patients. There was a strong donor effect.","DOI":"10.1053\/j.gastro.2015.04.001"},{"key":"562_CR24","doi-asserted-by":"crossref","unstructured":"Rossen NG et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology. 2015;149:110\u2013118 e4. Randomized controlled trial demonstrating that fecal microbial transplant was no better than placebo at inducing remission in ulcerative colitis patients.","DOI":"10.1053\/j.gastro.2015.03.045"},{"key":"562_CR25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1053\/j.gastro.2005.02.009","volume":"128","author":"SC Kim","year":"2005","unstructured":"Kim SC et al. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology. 2005;128:891\u2013906.","journal-title":"Gastroenterology"},{"key":"562_CR26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature07416","volume":"456","author":"K Cadwell","year":"2008","unstructured":"Cadwell K et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature. 2008;456:259\u201363.","journal-title":"Nature"},{"key":"562_CR27","first-page":"19","volume-title":"The inflammatory bowel disease yearbook. Volume 4","author":"JJ Hansen","year":"2007","unstructured":"Hansen JJ, Sartor RB. Insights provided by animal models into the pathogenesis and treatment of IBD. In: Bernstein C, editor. The inflammatory bowel disease yearbook. Volume 4. London: Remedica; 2007. p. 19\u201355."},{"key":"562_CR28","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1172\/JCI118921","volume":"98","author":"B Gulwani-Akolkar","year":"1996","unstructured":"Gulwani-Akolkar B et al. Selective expansion of specific T cell receptors in the inflamed colon of Crohn\u2019s disease. J Clin Invest. 1996;98:1344\u201354.","journal-title":"J Clin Invest"},{"key":"562_CR29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/mi.2013.51","volume":"7","author":"M Camus","year":"2014","unstructured":"Camus M et al. Oligoclonal expansions of mucosal T cells in Crohn\u2019s disease predominate in NKG2D-expressing CD4 T cells. Mucosal Immunol. 2014;7:325\u201334.","journal-title":"Mucosal Immunol"},{"key":"562_CR30","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1053\/j.gastro.2005.01.060","volume":"128","author":"AC Abadia-Molina","year":"2005","unstructured":"Abadia-Molina AC et al. In vivo generation of oligoclonal colitic CD4+ T-cell lines expressing a distinct T-cell receptor Vbeta. Gastroenterology. 2005;128:1268\u201377.","journal-title":"Gastroenterology"},{"key":"562_CR31","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/gut.33.9.1209","volume":"33","author":"MT Moss","year":"1992","unstructured":"Moss MT et al. Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn\u2019s disease and control tissues. Gut. 1992;33:1209\u201313.","journal-title":"Gut"},{"key":"562_CR32","doi-asserted-by":"crossref","first-page":"e5641","DOI":"10.1371\/journal.pone.0005641","volume":"4","author":"I Olsen","year":"2009","unstructured":"Olsen I et al. Isolation of Mycobacterium avium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn\u2019s disease patients. PLoS One. 2009;4:e5641.","journal-title":"PLoS One"},{"key":"562_CR33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI200420295","volume":"113","author":"MJ Lodes","year":"2004","unstructured":"Lodes MJ et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest. 2004;113:1296\u2013306.","journal-title":"J Clin Invest"},{"key":"562_CR34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.immuni.2014.03.005","volume":"40","author":"Y Goto","year":"2014","unstructured":"Goto Y et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity. 2014;40:594\u2013607.","journal-title":"Immunity"},{"key":"562_CR35","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature07240","volume":"455","author":"K Atarashi","year":"2008","unstructured":"Atarashi K et al. ATP drives lamina propria T(H)17 cell differentiation. Nature. 2008;455:808\u201312.","journal-title":"Nature"},{"key":"562_CR36","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1128\/IAI.01513-13","volume":"82","author":"CS Eun","year":"2014","unstructured":"Eun CS et al. Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10\u2212\/\u2212 mice. Infect Immun. 2014;82:2239\u201346.","journal-title":"Infect Immun"},{"key":"562_CR37","doi-asserted-by":"crossref","first-page":"e747","DOI":"10.1111\/j.1399-3038.2009.00923.x","volume":"21","author":"H Jyonouchi","year":"2010","unstructured":"Jyonouchi H, Geng L, Cushing-Ruby A, Monteiro IM. Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1\/Th17 cytokines in response to Candida, a luminal antigen. Pediatr Allergy Immunol. 2010;21:e747\u201355.","journal-title":"Pediatr Allergy Immunol"},{"key":"562_CR38","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/intimm\/5.11.1461","volume":"5","author":"F Powrie","year":"1993","unstructured":"Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol. 1993;5:1461\u201371.","journal-title":"Int Immunol"},{"key":"562_CR39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1084\/jem.178.1.237","volume":"178","author":"PJ Morrissey","year":"1993","unstructured":"Morrissey PJ, Charrier K, Braddy S, Liggitt D, Watson JD. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med. 1993;178:237\u201344.","journal-title":"J Exp Med"},{"key":"562_CR40","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1007\/s10620-012-2292-3","volume":"57","author":"JD Lord","year":"2012","unstructured":"Lord JD, Valliant-Saunders K, Hahn H, Thirlby RC, Ziegler SF. Paradoxically increased FOXP3+ T cells in IBD do not preferentially express the isoform of FOXP3 lacking exon 2. Dig Dis Sci. 2012;57:2846\u201355.","journal-title":"Dig Dis Sci"},{"key":"562_CR41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MIB.0000000000000242","volume":"21","author":"J Lord","year":"2015","unstructured":"Lord J, Chen J, Thirlby RC, Sherwood AM, Carlson CS. T-cell receptor sequencing reveals the clonal diversity and overlap of colonic effector and FOXP3+ T cells in ulcerative colitis. Inflamm Bowel Dis. 2015;21:19\u201330.","journal-title":"Inflamm Bowel Dis"},{"key":"562_CR42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12331","volume":"500","author":"K Atarashi","year":"2013","unstructured":"Atarashi K et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature. 2013;500:232\u20136. Demonstrates that administration of a mixture of human-derived Clostridia strains can reduce experimental colitis in mice.","journal-title":"Nature"},{"key":"562_CR43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi K et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331:337\u201341.","journal-title":"Science"},{"key":"562_CR44","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","volume":"504","author":"N Arpaia","year":"2013","unstructured":"Arpaia N et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451\u20135.","journal-title":"Nature"},{"key":"562_CR45","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504:446\u201350.","journal-title":"Nature"},{"key":"562_CR46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith PM et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341:569\u201373.","journal-title":"Science"},{"key":"562_CR47","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.1206095","volume":"332","author":"JL Round","year":"2011","unstructured":"Round JL et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science. 2011;332:974\u20137.","journal-title":"Science"},{"key":"562_CR48","doi-asserted-by":"crossref","first-page":"12204","DOI":"10.1073\/pnas.0909122107","volume":"107","author":"JL Round","year":"2010","unstructured":"Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107:12204\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"562_CR49","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.chom.2014.03.006","volume":"15","author":"S Dasgupta","year":"2014","unstructured":"Dasgupta S, Erturk-Hasdemir D, Ochoa-Reparaz J, Reinecker HC, Kasper DL. Plasmacytoid dendritic cells mediate anti-inflammatory responses to a gut commensal molecule via both innate and adaptive mechanisms. Cell Host Microbe. 2014;15:413\u201323.","journal-title":"Cell Host Microbe"},{"key":"562_CR50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chom.2012.08.004","volume":"12","author":"Y Shen","year":"2012","unstructured":"Shen Y et al. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe. 2012;12:509\u201320.","journal-title":"Cell Host Microbe"},{"key":"562_CR51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cell.2013.11.042","volume":"156","author":"D An","year":"2014","unstructured":"An D et al. Sphingolipids from a symbiotic microbe regulate homeostasis of host intestinal natural killer T cells. Cell. 2014;156:123\u201333. Demonstrates that neonatal exposure to certain bacterial-derived sphingolipids reduces pro-inflammatory invariant NK cells and susceptibility to experimental colitis in adulthood.","journal-title":"Cell"},{"key":"562_CR52","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1219328","volume":"336","author":"T Olszak","year":"2012","unstructured":"Olszak T et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science. 2012;336:489\u201393.","journal-title":"Science"},{"key":"562_CR53","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/0016-5085(91)90729-5","volume":"101","author":"S Schreiber","year":"1991","unstructured":"Schreiber S et al. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology. 1991;101:1020\u201330.","journal-title":"Gastroenterology"},{"key":"562_CR54","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1136\/gut.2007.138305","volume":"57","author":"D Fassi El","year":"2008","unstructured":"El Fassi D, Nielsen CH, Kjeldsen J, Clemmensen O, Hegedus L. Ulcerative colitis following B lymphocyte depletion with rituximab in a patient with Graves\u2019 disease. Gut. 2008;57:714\u20135.","journal-title":"Gut"},{"key":"562_CR55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcmgh.2015.01.002","volume":"1","author":"Y Mishima","year":"2015","unstructured":"Mishima Y, Liu B, Hansen JJ, Sartor RB. Resident bacteria-stimulated IL-10-secreting B cells ameliorate T cell-mediated colitis by inducing Tr-1 cells that require IL-27-signaling. Cell Mol Gastroenterol Hepatol. 2015;1:295\u2013310.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"562_CR56","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.chom.2007.09.013","volume":"2","author":"DA Peterson","year":"2007","unstructured":"Peterson DA, McNulty NP, Guruge JL, Gordon JI. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe. 2007;2:328\u201339.","journal-title":"Cell Host Microbe"},{"key":"562_CR57","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1126\/science.1077336","volume":"298","author":"S Fagarasan","year":"2002","unstructured":"Fagarasan S et al. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science. 2002;298:1424\u20137.","journal-title":"Science"},{"key":"562_CR58","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.4049\/jimmunol.166.8.4884","volume":"166","author":"A Iwasaki","year":"2001","unstructured":"Iwasaki A, Kelsall BL. Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer\u2019s patch dendritic cells. J Immunol. 2001;166:4884\u201390.","journal-title":"J Immunol"},{"key":"562_CR59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/mi.2007.8","volume":"1","author":"A Cerutti","year":"2008","unstructured":"Cerutti A. Location, location, location: B-cell differentiation in the gut lamina propria. Mucosal Immunol. 2008;1:8\u201310.","journal-title":"Mucosal Immunol"},{"key":"562_CR60","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2014.08.006","volume":"158","author":"NW Palm","year":"2014","unstructured":"Palm NW et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell. 2014;158:1000\u201310. First study to demonstrate that IgA preferentially binds to colitogenic luminal bacteria.","journal-title":"Cell"},{"key":"562_CR61","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0091-6749(05)80067-3","volume":"86","author":"A Saxon","year":"1990","unstructured":"Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol. 1990;86:202\u201310.","journal-title":"J Allergy Clin Immunol"},{"key":"562_CR62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1023203118100","volume":"18","author":"F Seibold","year":"1998","unstructured":"Seibold F, Brandwein S, Simpson S, Terhorst C, Elson CO. pANCA represents a cross-reactivity to enteric bacterial antigens. J Clin Immunol. 1998;18:153\u201360.","journal-title":"J Clin Immunol"},{"key":"562_CR63","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1128\/IAI.67.12.6510-6517.1999","volume":"67","author":"O Cohavy","year":"1999","unstructured":"Cohavy O et al. Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn\u2019s disease. Infect Immun. 1999;67:6510\u20137.","journal-title":"Infect Immun"},{"key":"562_CR64","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1128\/IAI.68.3.1542-1548.2000","volume":"68","author":"O Cohavy","year":"2000","unstructured":"Cohavy O et al. Colonic bacteria express an ulcerative colitis pANCA-related protein epitope. Infect Immun. 2000;68:1542\u20138.","journal-title":"Infect Immun"},{"key":"562_CR65","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/gut.2008.157818","volume":"59","author":"B Terjung","year":"2010","unstructured":"Terjung B et al. p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5 and cross-react with microbial protein FtsZ. Gut. 2010;59:808\u201316.","journal-title":"Gut"},{"key":"562_CR66","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/bmj.297.6656.1105","volume":"297","author":"J Main","year":"1988","unstructured":"Main J et al. Antibody to Saccharomyces cerevisiae (bakers\u2019 yeast) in Crohn\u2019s disease. BMJ. 1988;297:1105\u20136.","journal-title":"BMJ"},{"key":"562_CR67","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1572-0241.2001.03613.x","volume":"96","author":"M Peeters","year":"2001","unstructured":"Peeters M et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96:730\u20134.","journal-title":"Am J Gastroenterol"},{"key":"562_CR68","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1128\/IAI.70.12.6567-6575.2002","volume":"70","author":"B Wei","year":"2002","unstructured":"Wei B et al. Pseudomonas fluorescens encodes the Crohn\u2019s disease-associated I2 sequence and T-cell superantigen. Infect Immun. 2002;70:6567\u201375.","journal-title":"Infect Immun"},{"key":"562_CR69","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/gast.2002.35379","volume":"123","author":"CJ Landers","year":"2002","unstructured":"Landers CJ et al. Selected loss of tolerance evidenced by Crohn\u2019s disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002;123:689\u201399.","journal-title":"Gastroenterology"},{"key":"562_CR70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/gast.2000.8519","volume":"119","author":"CL Sutton","year":"2000","unstructured":"Sutton CL et al. Identification of a novel bacterial sequence associated with Crohn\u2019s disease. Gastroenterology. 2000;119:23\u201331.","journal-title":"Gastroenterology"},{"key":"562_CR71","doi-asserted-by":"crossref","unstructured":"Dotan I et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn\u2019s disease. Gastroenterology. 2006;131:366\u201378.","DOI":"10.1053\/j.gastro.2006.04.030"},{"key":"562_CR72","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2006.108043","volume":"56","author":"M Ferrante","year":"2007","unstructured":"Ferrante M et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut. 2007;56:1394\u2013403.","journal-title":"Gut"},{"key":"562_CR73","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1572-0241.2007.01652.x","volume":"103","author":"M Papp","year":"2008","unstructured":"Papp M et al. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2\/CARD15 genotype in a Hungarian IBD cohort. Am J Gastroenterol. 2008;103:665\u201381.","journal-title":"Am J Gastroenterol"},{"key":"562_CR74","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/MIB.0b013e318281f2a1","volume":"19","author":"AA Elkadri","year":"2013","unstructured":"Elkadri AA et al. Serum antibodies associated with complex inflammatory bowel disease. Inflamm Bowel Dis. 2013;19:1499\u2013505.","journal-title":"Inflamm Bowel Dis"},{"key":"562_CR75","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1053\/j.gastro.2005.03.046","volume":"128","author":"SR Targan","year":"2005","unstructured":"Targan SR et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn\u2019s disease. Gastroenterology. 2005;128:2020\u20138.","journal-title":"Gastroenterology"},{"key":"562_CR76","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2003.11.015","volume":"126","author":"WS Mow","year":"2004","unstructured":"Mow WS et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn\u2019s disease. Gastroenterology. 2004;126:414\u201324.","journal-title":"Gastroenterology"},{"key":"562_CR77","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1572-0241.2006.00456.x","volume":"101","author":"MC Dubinsky","year":"2006","unstructured":"Dubinsky MC et al. Serum immune responses predict rapid disease progression among children with Crohn\u2019s disease: immune responses predict disease progression. Am J Gastroenterol. 2006;101:360\u20137.","journal-title":"Am J Gastroenterol"},{"key":"562_CR78","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/gutjnl-2012-302717","volume":"62","author":"FD Schaik van","year":"2013","unstructured":"van Schaik FD et al. Serological markers predict inflammatory bowel disease years before the diagnosis. Gut. 2013;62:683\u20138.","journal-title":"Gut"},{"key":"562_CR79","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/MIB.0b013e318280b19e","volume":"19","author":"S Plevy","year":"2013","unstructured":"Plevy S et al. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn\u2019s disease, and ulcerative colitis patients. Inflamm Bowel Dis. 2013;19:1139\u201348.","journal-title":"Inflamm Bowel Dis"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-015-0562-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11882-015-0562-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-015-0562-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T14:45:00Z","timestamp":1599489900000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11882-015-0562-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,26]]},"references-count":79,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1007\/s11882-015-0562-9","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,26]]},"article-number":"61"}}